Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)



Rating:

Share or cite this content

Citations should be made in the following way:
G.B. Migliori (Tradate, Italy). Evidence provided by recent meta-analyses on treatment: what is new?. Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)

Member's Comments

No comment yet.

Related content which might interest you: Current evidence for COVID-19 therapies: a systematic literature review Source: Eur Respir Rev, 30 (159) 200384; 10.1183/16000617.0384-2020 Year: 2021 Establishing new treatments: the role of RCTs Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies Year: 2020 Efficacy of acupuncture in asthma: systematic review and meta-analysis of published data from 11 randomised controlled trials Source: Eur Respir J 2002; 20: 846-852 Year: 2002 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 As needed therapies in mild to severe asthma: a systematic review and network meta-analysis Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Do we have enough evidence overall, or should we wait for ongoing trials? Source: International Congress 2014 – From respiratory infections to wheezing: reevaluating the role of vitamin D levels in childhood Year: 2014 Classification of antituberculosis drugs: a new proposal based on the most recent evidence Source: Eur Respir J 2015; 46: 887-893 Year: 2015 Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Comparison of the treatment guidelines for sarcoidosis: common sense in the search for evidence Source: Eur Respir J, 59 (2) 2103114; 10.1183/13993003.03114-2021 Year: 2022 A systematic review and meta-analysis of complementary and alternative medicine in asthma Source: Eur Respir Rev 2017; 26: 160092 Year: 2017 The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis Source: Eur Respir J, 58 (6) 2100266; 10.1183/13993003.00266-2021 Year: 2021 Anti-IgE therapy: rationale and clinical evidence Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives Year: 2007 Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence Source: Eur Respir J, 50 (5) 1701462; 10.1183/13993003.01462-2017 Year: 2017 Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study Source: Eur Respir J, 53 (5) 1802161; 10.1183/13993003.02161-2018 Year: 2019 Operational definitions of paediatric asthma used in epidemiological studies: A systematic review Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020 Quality of resistance training description in COPD trials: a systematic review Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017 Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Clinical effectiveness and models of pulmonary rehabilitation in low-resource-settings: a systematic review Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation Year: 2019 Clinical effectiveness of triple therapy in the management of COPD: A systematic review Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010